Filing Details
- Accession Number:
- 0001209191-13-055995
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-09 19:55:04
- Reporting Period:
- 2013-12-05
- Filing Date:
- 2013-12-09
- Accepted Time:
- 2013-12-09 19:55:04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1411158 | Anacor Pharmaceuticals Inc. | ANAC | Pharmaceutical Preparations (2834) | 251854385 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1105941 | P David Perry | C/O Anacor Pharmaceuticals, Inc. 1020 East Meadow Circle Palo Alto CA 94303 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-12-05 | 12,100 | $15.18 | 249,054 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-12-05 | 2,900 | $15.67 | 246,154 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-12-06 | 5,200 | $16.58 | 240,954 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-12-06 | 9,800 | $16.99 | 231,154 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-12-09 | 285,480 | $0.60 | 516,634 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-12-09 | 10,328 | $16.72 | 506,306 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2013-12-09 | 285,480 | $0.00 | 285,480 | $0.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2009-06-03 | 2015-08-25 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopetd by the reporting person on November 19, 2013.
- The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $14.6100 to $15.5000, inclusive.
- The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $15.5050 to $15.8650, inclusive.
- The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $15.9000 to $16.7900, inclusive.
- The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.8000 to $17.3700, inclusive.
- The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.69 to $16.84, inclusive.